Just like the United States does, New Zealand allows DTC pharma advertising. And just like in the U.S., many doctors there would like to ban the ads.
Similarly to the first weekend of real NCAA March Madness tournament play, DTC #FierceMadness Round 1 featured close calls, blowouts and surprises.
Novartis' slow-starting heart failure med Entresto reduced patients' blood sugar levels more than a head-to-head rival did, a new analysis shows.…
Only one of the three leading next-gen anticoagulants showed it could save the healthcare system hundreds of dollars per patient in a new real-world study.
A new delay for Pfizer and Merck KGaA with I-O candidate avelumab in the lung cancer space will put the pair of drugmakers years behind their first-line rivals.
Health authorities in the U.K. said CAR-T therapies could cost $649,000 to treat acute lymphoblastic leukemia in children.
Get ready to negotiate, payers: Amgen has its PCSK9 outcomes data. In a long-awaited trial, Repatha cut heart attack risks by 27% and stroke risks by 21%. Will…
Sen. Bernie Sanders and Rep. Elijah Cummings have 'serious questions' for the FDA after its approval of Marathon's controversial Duchenne med…
Merck's Keytruda has won a green light in lymphoma, one of two indications where it had scored priority review last year.
Merck & Co. and Bristol-Myers Squibb's cancer drugs headlined the pharma TV ad spending chart for February with a hefty total of $33 million.